Back to News
Cata-Kor Receives NSF Certification for Liposomal Glutathione Formulation
Source: feeds.newsfilecorp.com
Healthcare & BiotechCompany Fundamentals
The provided article text contains only a brief company description of Cata-Kor as a U.S. nutraceutical firm focused on science-informed longevity formulations, without any disclosed financial results, guidance, deals, regulatory actions, or market-moving details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- CoreWeave credit default swaps hit distress levels as investors sour on AI debt
- Penske Automotive agrees to be taken private by Penske, Mitsui
- Supermicro promised a new CFO in December 2024. A $2.5 billion smuggling case and a co-founder’s arrest later, it has one
- Blackstone President Jon Gray Bets Big on AI Boom
- What's behind the sell-off in AI neocloud stocks like CoreWeave and Nebius
- Giant Taiwanese chipmaker TSMC confirms it’s in talks with Elon Musk to join ‘Terafab’ complex in Texas: ‘The AI market continues to be very strong’